← FDA DRUG APPROVALS

FDA ANDA · ANDA080210

LIDOCAINE

Sponsor: BELMORA LLC

APPLICATION
ANDA080210
TYPE
ANDA
ORIGINAL APPROVAL
1971-06-30
LATEST ACTION
1990-01-04
ROUTE
TOPICAL
DOSAGE FORM
OINTMENT
MARKETING STATUS
Discontinued

Products

LIDOCAINEDiscontinued
LIDOCAINE 5% · OINTMENT · TOPICAL

Approval history

1990-01-04Labeling · Supplement 8AP
1971-06-30OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →